NCT00001577 2008-03-04Pilot Study of a Double Isolation Perfusion Schedule Using Melphalan Alone for Intransit Melanoma or Unresectable Sarcoma of the ExtremityNational Institutes of Health Clinical Center (CC)Phase 1 Completed30 enrolled